Metraipolis › archive › dc_bd3ab7a8fe3f

Ginkgo Biloba for Alzheimer's Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment-What Have We Learned over Two Decades, and… — Europe PMC PMID:42041838

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42041838
DOI
10.3390/brainsci16040430
License (as archived)
solo-consultazione
Archived
2026-10-17T07:38:27.830Z
SHA-256 of the archived text
77611b081d30094cf28c0af2c3f38195d78260eddaac5b4d57f5980399e8dd73
Stable URL of this page
https://metraipolis.com/documento/dc_bd3ab7a8fe3f

How to cite

Ginkgo Biloba for Alzheimer's Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment-What Have We Learned over Two Decades, and… — Europe PMC PMID:42041838 — Europe PMC (en), https://europepmc.org/article/MED/42041838 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd3ab7a8fe3f (Metraipolis archive dc_bd3ab7a8fe3f, sha256 77611b081d30094cf28c0af2c3f38195d78260eddaac5b4d57f5980399e8dd73)
BibTeX
@misc{dcbd3ab7a8fe3f,
  title = {Ginkgo Biloba for Alzheimer's Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment-What Have We Learned over Two Decades, and… — Europe PMC PMID:42041838},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42041838},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd3ab7a8fe3f; sha256 77611b081d30094cf28c0af2c3f38195d78260eddaac5b4d57f5980399e8dd73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42041838. Agents can read the archived copy with the MCP tool read_document.